Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

Lykke Midtbøll Ørnbjerg*, Cecilie Heegaard Brahe, Louise Linde, Lennart Jacobsson, Michael J. Nissen, Eirik Klami Kristianslund, Maria José Santos, Dan Nordström, Ziga Rotar, Bjorn Gudbjornsson, Fatos Onen, Catalin Codreanu, Ulf Lindström, Burkhard Möller, Tore K. Kvien, Anabela Barcelos, Kari K. Eklund, Matija Tomšič, Thorvardur Jon Love, Gercek CanRuxandra Ionescu, Anne Gitte Loft, Herman Mann, Karel Pavelka, Marleen van de Sande, I. E. van der Horst-Bruinsma, Manuel Pombo Suarez, Carlos Sánchez-Piedra, Gary J. Macfarlane, Florenzo Iannone, Brigitte Michelsen, Lise Hejl Hyldstrup, Niels Steen Krogh, Mikkel Østergaard, Merete Lund Hetland

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science